Amarantus BioScience Holdings, Inc.

AMBS · OTC
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Operating Activities
Net Income-$52-$1,405$336-$632
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$60$60$61$64
Other Non-Cash-$60-$60-$61$18
Operating Cash Flow$8-$1,345$397-$547
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0-$3,551$3,551
Other Inv. Act.-$8$1,345$3,153-$3,004
Investing Cash Flow-$8$1,345-$397$547
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$0$0$0-$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash-$0$0$0$0
Free Cash Flow$8-$1,345$397-$547